🇺🇸 FDA
Patent

US 7276643

Transgenic animals, cell lines derived therefrom, and methods for screening for anti-amyloidogenic agents

granted A61KA61K38/00A61K48/00

Quick answer

US patent 7276643 (Transgenic animals, cell lines derived therefrom, and methods for screening for anti-amyloidogenic agents) held by The Regents of the University of California expires Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 02 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 27 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
7
CPC classes
A61K, A61K38/00, A61K48/00, A61P, A61P35/00